REV-MED recently participated in the ACCO2024 (Annual Congress of Cartilage and Osteoarthritis), presenting the excellence of its NovaStem and Hilthera 4.0 products.
Professor Seokjung Kim from the Orthopedic Department of Uijeongbu St. Mary's Hospital delivered a lecture during the event. He shared treatment methods and techniques using bone marrow stem cells and growth factors collected from various clinical environments. His presentation included successful cases of combining existing treatments with stem cell-based therapies, drawing significant attention.
At its booth, REV-MED showcased the NovaStem product line, widely used in osteoarthritis treatments. A company representative stated, "The NovaStem kit enables highly concentrated extraction of autologous cells from bone marrow or blood with minimal manipulation. Its chamber design effectively separates red blood cells, making it advantageous for concentrating viable cells."
Additionally, Hilthera 4.0, also on display, demonstrated its ability to deliver safe, heat-free laser energy to deep tissues, aiding in pain relief and various treatments. The device is highly effective for osteoarthritis and tissue regeneration therapies.
Source : DailyMedi https://www.dailymedi.com/news/news_view.php?wr_id=917871
REV-MED recently participated in the ACCO2024 (Annual Congress of Cartilage and Osteoarthritis), presenting the excellence of its NovaStem and Hilthera 4.0 products.
Professor Seokjung Kim from the Orthopedic Department of Uijeongbu St. Mary's Hospital delivered a lecture during the event. He shared treatment methods and techniques using bone marrow stem cells and growth factors collected from various clinical environments. His presentation included successful cases of combining existing treatments with stem cell-based therapies, drawing significant attention.
At its booth, REV-MED showcased the NovaStem product line, widely used in osteoarthritis treatments. A company representative stated, "The NovaStem kit enables highly concentrated extraction of autologous cells from bone marrow or blood with minimal manipulation. Its chamber design effectively separates red blood cells, making it advantageous for concentrating viable cells."
Additionally, Hilthera 4.0, also on display, demonstrated its ability to deliver safe, heat-free laser energy to deep tissues, aiding in pain relief and various treatments. The device is highly effective for osteoarthritis and tissue regeneration therapies.
Source : DailyMedi https://www.dailymedi.com/news/news_view.php?wr_id=917871